IPCA Laboratories Ltd (NSE: IPCALAB): IPCA Laboratories Ltd has released its quarterly results. The profit has grown on an annual base.
According to information published on the exchange website, compared to the quarter of July-September of the financial years 2023-24, profit increased from Rs 145 crores to Rs 229 crores in the quarter of July-September of the financial years 2024-25.
The income has increased from Rs 2,034 crores to Rs 2,355 crores. EBITDA-working profit has increased from Rs 357 crores to Rs 442 crores.
EBITDA has risen from 17.6 percent to 18.8 percent. To please investors, the company also paid a Rs 2 dividend per share.
Nava Ltd Q2
Results of the past three quarters were published. The annual profit is up.
According to information published on the exchange, the profit increased from Rs 148 crores to Rs 251 crores in the quarter of July-September of the financial years 2024-25 compared to the quarter of July-September of the financial years 2023-24.
The income has dropped from Rs 922 crore to Rs 900 crore. EBITDA working profit increased from Rs 359 crore to Rs 413 crore.
EBITDA has increased from 38.9 percent to 45.9 percent.
Global Health Q2
The results for the last three months have been published. The profit has grown every year.
According to information published on the exchange, the profit increased from Rs 125 crore to Rs 131 crore during the quarter of July-September of the financial year 2024-25 compared to that of the quarter of July-September of the fiscal year 2023-24.
The income has increased from Rs 850 crores to Rs 957 crores. EBITDA and working profit have increased from Rs 219 crores to Rs 228 crores.
EBITDA margin dropped from 25.8 percent to 23.9 percent.
Bharat Dynamics Q2
The results for the last three months have been published. The profit has grown on an annual base.
According to information published on the exchange, the profit for the quarter of July-September of the financial years 2023-24 and 2024-25 has decreased from Rs 147 crore to Rs 123 crore.
The income has dropped from Rs 616 crore to Rs 545 crore. EBITDA working profit dropped from Rs 134 crore to Rs 99 crore.
EBITDA has dropped from 21.8 percent to 18.1 percent.
JTEKT India Q2
The results for the last three months have been published. The profit has grown on an annual base.
According to information published on the exchange, the profit fell from Rs 30.2 crore to Rs 19.5 crore in the quarter of July-September of the fiscal year 2024-25 compared to that of the quarter of July-September of the fiscal year 2023-24.
The income has increased from Rs 584 crores to Rs 605.3 crores. EBITDA-working profit has decreased from Rs 60.3 crore to Rs 47.3 crore.
EBITDA margin dropped from 10.3 percent down to 7.8 percent.
Quick Fact
Company name: Ipca Laboratories
| Ipca Laboratories | Details |
|---|---|
| Profit (Annual) | ₹145 crore to ₹229 crore |
| Income | ₹2,034 crore to ₹2,355 crore |
| EBITDA | ₹357 crore to ₹442 crore |
| EBITDA Margin | 17.6% to 18.8% |
| Dividend per Share | ₹2 |
Company name: Nava
| Nava | Details |
|---|---|
| Profit (Annual) | ₹148 crore to ₹251 crore |
| Income | ₹922 crore to ₹900 crore |
| EBITDA | ₹359 crore to ₹413 crore |
| EBITDA Margin | 38.9% to 45.9% |
Company name: Global Health
| Global Health | Details |
|---|---|
| Profit (Annual) | ₹125 crore to ₹131 crore |
| Income | ₹850 crore to ₹957 crore |
| EBITDA | ₹219 crore to ₹228 crore |
| EBITDA Margin | 25.8% to 23.9% |
Company name: Bharat Dynamics
| Bharat Dynamics | Details |
|---|---|
| Profit (Annual) | ₹147 crore to ₹123 crore |
| Income | ₹616 crore to ₹545 crore |
| EBITDA | ₹134 crore to ₹99 crore |
| EBITDA Margin | 21.8% to 18.1% |
Company name: JTEKT India
| JTEKT India | Details |
|---|---|
| Profit (Annual) | ₹30.2 crore to ₹19.5 crore |
| Income | ₹584 crore to ₹605.3 crore |
| EBITDA | ₹60.3 crore to ₹47.3 crore |
| EBITDA Margin | 10.3% to 7.8% |
Disclaimer: The website and its content are for informational purposes only and should not be considered investment advice.